Skip to main content

Tilly's, Inc. (TLYS) Stock Forecast

Data as of Jun 16, 2026

Consumer Cyclical · Current price $4.63 (-9.22%)

Consensus Target
$9.50
Upside
+1.7%
Analysts
Rating

Price Target Range

Low $7.00Consensus $9.50High $12.00
▲ Current $4.63

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Jun 7, 2024Jeff Van SinderenB.Riley Financial$7.00+51.2%
Jun 18, 2022Mitch KummetzSeaport Global$12.00+159.2%

TLYS vs Sector & Market

MetricTLYSConsumer Cyclical AvgLarge Cap Avg
Analyst Rating2.512.40
Analyst Count1319
Target Upside+1.7%+387.4%+17.1%
P/E Ratio18.4813.7931.64

Revenue Estimates

PeriodLowAvgHigh#
2027-01-31$568M$568M$568M1
2028-01-31$578M$578M$578M1

EPS Estimates

PeriodLowAvgHigh#
2027-01-31$-0.17$-0.17$-0.171
2028-01-31$-0.16$-0.16$-0.161

Frequently Asked Questions

What is the analyst consensus for TLYS?

The consensus among 0 analysts covering Tilly's, Inc. (TLYS) is — with an average price target of $9.50.

What is the highest price target for TLYS?

The highest price target for TLYS is $12.00, set by Mitch Kummetz at Seaport Global on 2022-06-18.

What is the lowest price target for TLYS?

The lowest price target for TLYS is $7.00, set by Jeff Van Sinderen at B.Riley Financial on 2024-06-07.

How many analysts cover TLYS?

0 analysts have issued ratings for Tilly's, Inc. in the past 12 months.

Is TLYS a buy or sell right now?

Based on 0 analyst ratings, TLYS has a consensus rating of — with a +1.7% upside to the consensus target of $9.50.

What are the earnings estimates for TLYS?

Analysts estimate TLYS will report EPS of $-0.17 for the period ending 2027-01-31, with revenue estimated at $568M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.